Evaxion AS (EVAX)
5.09
+0.01
(+0.20%)
USD |
NASDAQ |
Jan 12, 10:35
Evaxion Research and Development Expense (Annual): 10.14M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Novo Nordisk A/S | 5.514B |
| Ascendis Pharma A/S | 324.02M |
| DBV Technologies SA | 89.90M |
| Cellectis SA | 72.02M |
| Akari Therapeutics Plc | 6.986M |